LUCD
Lucid Diagnostics Inc.
-0.05 (-6.08%)0.79USD574K成交股數160M市值–本益比(近四季)29.3股價營收比+26.7%營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.5M+27% | 1.3M+52% | 1.5M+28% | 1.2M+24% | 1.2M+16% | 828K-20% | 1.2M+50% | 976K+514% | 1.0M | 1.0M | 783K | 159K |
| 營業成本 | 1.4M | 1.6M | – | – | 1.6M | 1.6M | – | – | – | – | – | – |
| 毛利 | 29K-107% | −369K-49% | – | – | −400K | −723K | – | – | – | – | – | – |
| 毛利率 | 2.0% | -29.4% | – | – | -34.4% | -87.3% | – | – | – | – | – | – |
| 研發費用 | 1.2M | 1.2M | 1.7M | 1.3M | 1.3M | 1.4M | 1.7M | 1.4M | 1.5M | 1.9M | 1.6M | 1.8M |
| 銷售管理費用 | 5.8M | 5.4M | 6.5M | 5.6M | 5.6M | 6.2M | 5.4M | 4.9M | 4.1M | 4.2M | 4.3M | 3.8M |
| 營業利益 | −12.8M+12% | −12.1M-3% | −14.0M+20% | −11.8M+5% | −11.4M+5% | −12.5M+9% | −11.7M+5% | −11.2M-3% | −10.8M | −11.5M | −11.1M | −11.6M |
| 營業利益率 | -868.5% | -964.5% | -931.5% | -971.0% | -978.8% | -1,508.1% | -997.8% | -1,146.7% | -1,078.1% | -1,101.3% | -1,421.2% | -7,285.5% |
| 稅後淨利 | −11.7M+163% | −13.9M-48% | −16.3M+31% | −10.4M-6% | −4.4M-58% | −26.9M+148% | −12.4M-13% | −11.0M-3% | −10.6M | −10.8M | −14.2M | −11.4M |
| 淨利率 | -792.9% | -1,107.4% | -1,081.5% | -858.5% | -381.7% | -3,249.8% | -1,055.5% | -1,127.6% | -1,060.1% | -1,041.3% | -1,814.6% | -7,157.9% |
| 稀釋 EPS | – | – | – | -0.10-57% | -0.08-80% | -0.52+108% | -0.25-26% | -0.23-15% | -0.40 | -0.25 | -0.34 | -0.27 |
| 稀釋股數 | – | – | – | 108M | 99.0M | 68.8M | 50.4M | 48.2M | 45.0M | 41.8M | 41.9M | 41.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | – | – | – | 47.3M | 31.1M | 25.2M | 14.5M | 24.9M | 24.8M | 18.9M | 24.1M | 32.6M |
| 應收帳款 | 1.1M | 689K | 643K | 550K | 373K | 61K | 39K | 160K | 49K | 45K | 21K | 35K |
| 存貨 | 484K | 469K | 353K | 486K | 505K | 484K | 651K | 683K | 410K | 278K | – | – |
| 總資產 | 38.9M | 34.1M | 40.4M | 53.2M | 38.7M | 32.8M | 22.6M | 34.1M | 32.0M | 27.3M | 33.2M | 42.5M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 28.0M | 30.1M | 29.5M | 27.4M | 30.8M | 38.2M | 16.3M | 18.1M | 20.2M | 29.6M | 30.7M | 27.4M |
| 股東權益 | 10.9M | 4.0M | 10.9M | 25.8M | 7.9M | −5.4M | 6.3M | 16.0M | 11.9M | −2.3M | 2.6M | 15.1M |
| 負債比 | 71.9% | 88.3% | 73.0% | 51.4% | 79.7% | 116.4% | 72.0% | 53.2% | 62.9% | 108.5% | 92.3% | 64.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −12.1M-3% | – | – | – | −12.5M | – | – | −12.6M | – | – | – |
| 資本支出 | – | 215K | – | – | – | 93K | – | – | – | – | – | – |
| 自由現金流 | – | −12.3M-2% | – | – | – | −12.6M | – | – | – | – | – | – |
| 折舊攤銷 | – | 222K | – | – | – | 221K | – | – | 501K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -980.6% | – | – | – | -1,516.7% | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 4.7M | +8.3% | −58.0M | -1,232.7% | – | −46.7M |
| FY2024 | 4.3M | +79.0% | −45.5M | -1,047.6% | -1.05 | −44.4M |
| FY2023 | 2.4M | +544.0% | −52.7M | -2,169.1% | -1.26 | – |
| FY2022 | 377K | -24.6% | −56.2M | -14,899.5% | -1.55 | −32.9M |
| FY2021 | 500K | – | −28.1M | -5,615.6% | -1.51 | −18.5M |
| FY2020 | – | – | −8.3M | –% | -0.59 | – |